Originally published by FinSMEs on November 25, 2022
Aide Health, a London, UK-based health-tech startup, raised £1M in Pre-Seed funding.
The round was led by Hambro Perks through its EIS fund, with participation from Fuel Ventures, 1818 Ventures and APX Ventures.
The company intends to use the funds to expand its services to include hypertension and chronic pain.
Co-founded by Ian Wharton (CEO) and Brian Snyde, Aide is a digital platform that helps patients and their clinicians understand and manage long-term health conditions, such as type-2 diabetes, heart disease, asthma, and IBD, paired with a mobile app for the patient which acts as a co-pilot through their care. Using natural language, Aide has short, daily conversations to help with the day-to-day management of health conditions through medicines optimisation, structured monitoring and structured education.
The service is currently being used by the NHS, with a pilot launched earlier this year supporting people aged between 18-75 with asthma or type-2 diabetes.